Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
NSE - Delayed Quote INR

TAKE Solutions Limited (TAKE.NS)

Compare
18.95 -0.10 (-0.52%)
At close: 3:30 PM GMT+5:30
Loading Chart for TAKE.NS
DELL

TAKE Solutions Limited Overview Biotechnology / Healthcare

TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient centricity insight in life science sector; and payer solutions, including access to billing insight through cloud adoption. In addition, the company offers payer-provider digital solution, which includes personalized medicine, wellness, and patient engagement; and medical device solution, such as technological transformation with chip level programming, wearables, DICOM devices, PROM, nano devices, and miOTs. TAKE Solutions Limited was incorporated in 2000 and is headquartered in Chennai, India. TAKE Solutions Limited is a subsidiary of TAKE Solutions Pte. Limited.

www.takesolutions.com

203

Full Time Employees

March 31

Fiscal Year Ends

Related News

View More

Performance Overview: TAKE.NS

Trailing total returns as of 8/29/2024, which may include dividends or other distributions. Benchmark is

S&P BSE SENSEX
.

YTD Return

TAKE.NS
17.79%
S&P BSE SENSEX
13.70%

1-Year Return

TAKE.NS
3.84%
S&P BSE SENSEX
26.37%

3-Year Return

TAKE.NS
63.77%
S&P BSE SENSEX
46.34%

5-Year Return

TAKE.NS
83.89%
S&P BSE SENSEX
119.31%

Compare To: TAKE.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TAKE.NS

View More

Valuation Measures

Annual
As of 8/28/2024
  • Market Cap

    2.79B

  • Enterprise Value

    3.15B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.25

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    4.80

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -182.32%

  • Return on Assets (ttm)

    -8.28%

  • Return on Equity (ttm)

    -239.89%

  • Revenue (ttm)

    656.08M

  • Net Income Avi to Common (ttm)

    -1.2B

  • Diluted EPS (ttm)

    -8.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.49M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    188.38M

Research Analysis: TAKE.NS

View More

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

 

Company Insights: TAKE.NS

People Also Watch